Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Myeloid 1

Conditions

Urinary Bladder Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1

Interventions

fludarabine 26Azacitidine 24venetoclax 23Cyclophosphamide 21Specimen Handling 19fludarabine phosphate 17Busulfan 15Biopsy 15Whole-Body Irradiation 14Mycophenolic Acid 14Melphalan 14Tacrolimus 13Cytarabine 13Granulocyte Colony-Stimulating Factor 11Decitabine 10decitabine and cedazuridine drug combination 9Stem Cell Transplantation 9Sirolimus 9Injections 9Cyclosporine 9Peripheral Blood Stem Cell Transplantation 8Filgrastim 8Thiotepa 7ruxolitinib 5X-Rays 5Idarubicin 5Methotrexate 4Magnetic Resonance Spectroscopy 4Cyclosporins 4Cladribine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic Syndromes × Home Care Services × 90 days × Clear all
NCT05969860 2026-04-20

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Mayo Clinic

Phase 2 Recruiting
220 enrolled
MyeloidPlasma cell

Multiple Myeloma, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡